[vc_row][vc_column][vc_column_text] The ISN Clinical and Research Program funded specific research into the efficiency of kinkeliba on non-complicated hypersensitive patients. The project was awarded USD 15,000 in 2013. Completed in early 2014, it received the best clinical research prize at the 2015 ISN World Congress of Nephrology congress and the 10th Conference on Kidney Disease in Disadvantaged...
[vc_row][vc_column][vc_column_text] A study undertaken during 2015 at Queen Elizabeth Central Hospital (QECH), Blantyre, Malawi demonstrated that 20% of general medical admissions over a three-month period had evidence of kidney disease. Outcome (hospital mortality) in these patients was significantly worse than those with normal renal function. In response to this, and in line with the Ministry of...
[vc_row][vc_column][vc_column_text] The ISN Renal Disaster Relief Task Force (RDRTF) has released its first report following the earthquake that struck Ecuador on April 17, 2016. Chair of RDRTF Wim Van Biesen stated that the committee had been in contact with local ISN representatives in the region, the national nephrology society of Ecuador, and some local nephrologists (Cristobal...
[vc_row][vc_column][vc_column_text]A dialysis patient referred me to this article from The Atlantic. Published in 2010 but still worth reading. The ISN is all about closing gaps in the provision of kidney care worldwide, but when we think of "gaps", we tend to think of emerging countries, places in Africa or the poorest parts of Asia and Latin...
[vc_row][vc_column][vc_column_text] The Global Kidney Health Atlas (GKHA), part of the ISN Closing The Gaps CKD initiative, is co-chaired by Professor David Johnson (University of Queensland, Australia) and Dr Aminu Bello (University of Alberta, Canada). The purpose is to systematically evaluate the current state of readiness, capacity and competence for delivering kidney health care globally. World nations are being pushed...
[vc_row][vc_column][vc_column_text] The ISN Advancing Clinical Trials (ISN-ACT) group is a new ISN Initiative to leverage existing infrastructures within ISN to improve how the global nephrology community conducts and participates in clinical trial research, through a series of activities and initiatives. The aim of ISN-ACT is to increase the number of international high-quality clinical trials in nephrology,...
[vc_row][vc_column][vc_column_text] The Young Nephrologists Committee (YNC) would like to welcome its new Chair Rolando Claure-Del Granado, who will take over from Jeffrey Perl. Many thanks to Jeffrey for his dedicated efforts in the last few years. Perl says: “We have seen our committee grow in breadth and scope with representation from across the globe. Workshops to improve...
[vc_row][vc_column][vc_column_text] As of April 29, 2016, send your abstracts and register for the ISN Forefronts symposium taking place in Vienna from December 9 to 11, 2016. The theme for this meeting is regulatory RNAs and the kidney. Non-coding RNAs regulate normal cellular functions but are also critical regulators of disease processes. Therefore, they are being explored...
[vc_row][vc_column][vc_column_text]Having returned from spending a month working with the renal team Queen Elizabeth Hospital in Blantyre, Malawi, I wanted to blog about what nephrologists and nephrology researchers are up against in the country. I had the pleasure of working with a dedicated team of people on a current research study focusing on children suffering from...
[vc_row][vc_column][vc_column_text]The outcome of the Acute Kidney Injury (AKI) Global Snapshot, an innovative web-based global cohort study carried out under the ISN 0by25 Initiative, is published in The Lancet today. Including 4,000 patients in over 72 countries, the study assessed similarities and differences in recognizing and managing AKI globally. The study found that over half of the patients in...
